Investigating the ways in which mutations responsible for NBIA disorders affect the function of the enzymes encoded by the PLA2G6 and PANK2 genes.

Developing treatments that improve the function of enzymes affected by disease-causing mutations.

Developing treatments to compensate for the loss of enzyme function by addressing metabolic deficiencies that occur when enzymes do not function properly.